P. Cacciottolo

发表

Left bundle branch block with acute thrombotic occlusion is associated with increased myocardial jeopardy score and poor clinical outcomes in primary percutaneous coronary intervention activations

P. Schofield, Adam J. Brown, N. West, 2013, Heart.

Cardiac Transplantation following Cobalt Cardiomyopathy from Bilateral Metal-on-Metal Hip Replacements

F. Falter, S. Pettit, P. Cacciottolo, 2022, Case reports in anesthesiology.

Freedom from reoperation 38 years after a ross procedure performed in middle age--what can we learn from this remarkable survival?

L. Freeman, I. Rafiq, P. Cacciottolo, 2016, International journal of cardiology.

Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial

J. H. Rudd, E. Vamvaka, J. Tarkin, 2020, BMJ Open.

Low- dose i nterleukin 2 for the reduction of v ascular inflammati o n in acute corona ry syndromes (IVORY): protocol and study rationale for a randomised, double- blind, placebo- controlled, phase II clinical trial

J. H. Rudd, E. Vamvaka, J. Tarkin, 2022 .

Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study

I. Wilkinson, C. McEniery, E. Vamvaka, 2021, BMJ Open.

Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers – a mechanistic physiological study (INTENSITY-LOW): protocol and study rationale

I. Wilkinson, M. Kostapanos, J. Cheriyan, 2019, Journal of drug assessment.

HPV positivity varies with technique and primer set, in formalin-fixed paraffin-embedded benign and malignant breast tissue from Malta

P. Schembri-Wismayer, C. Camenzuli, J. Borg, 2011 .

Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers – a mechanistic physiological study (INTENSITY-LOW): protocol and study rationale

I. Wilkinson, M. Kostapanos, J. Cheriyan, 2019, Journal of drug assessment.

Left bundle branch block with acute thrombotic occlusion is associated with increased myocardial jeopardy score and poor clinical outcomes in primary percutaneous coronary intervention activations

P. Schofield, N. West, L. McCormick, 2013, Heart.